Matthias Hartmann-Riemer

Matthias Hartmann-Riemer

Auto-generated profile, based on publicly available information

Matthias Hartmann-Riemer

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland; Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2014 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
MHMatthias N. Hartmann
Matthias N. Hartmann
OHOliver M. Hager
Oliver M. Hager
ARAnna V. Reimann
Anna V. Reimann
JCJustin R. Chumbley
Justin R. Chumbley
MKMatthias Kirschner
Matthias Kirschner
SKStefan Kaiser
Stefan Kaiser
Negative symptoms in schizophrenia have been grouped into the 2 factors of apathy and diminished expression , which might be caused by separable pathophysiological mechanisms. Recently, it has been proposed that apathy could be due to dysfunctional integration of reward and effort during decision making. We asked whether apathy in particular is associated with stronger devaluation (“discounting”) of monetary rewards that require physical effort. Thirty-one patients with schizophrenia and 20 healthy control participants performed a computerized effort discounting task in which they could choose to exert physical effort on a handgrip to obtain monetary rewards. This procedure yields an individual measure for the strength of effort discounting. The degree of effort discounting was strongly correlated with apathy, but not with diminished expression. Importantly, the association between apathy and effort discounting was not driven by cognitive ability, antipsychotic medication, or other clinical and demographic variables. This study provides the first evidence for a highly specific association of apathy with effort-based decision making in patients with schizophrenia. Within a translational framework, the present effort discounting task could provide a bridge between apathy as a psychopathological phenomenon and established behavioral tasks to address similar states in animals.

1 November 2013 in Behavioural Processes
Verified
Journal Article
Closed access
MHMatthias N. Hartmann
Matthias N. Hartmann
OHOliver M. Hager
Oliver M. Hager
PTPhilippe N. Tobler
Philippe N. Tobler
SKStefan Kaiser
Stefan Kaiser

9 September 2015 in Frontiers in Behavioral Neuroscience
Verified
Journal Article
Open access
PDF file
FCFlurin Cathomas
Flurin Cathomas
MHMatthias N. Hartmann
Matthias N. Hartmann
ESErich Seifritz
Erich Seifritz
CPChristopher R. Pryce
Christopher R. Pryce
SKStefan Kaiser
Stefan Kaiser
Apathy, a quantitative reduction in goal-directed behavior, is a prevalent symptom dimension with a negative impact on functional outcome in various neuropsychiatric disorders including schizophrenia and depression. The aim of this review is to show that interview-based assessment of apathy in humans and observation of spontaneous rodent behavior in an ecological setting can serve as an important complementary approach to already existing task-based assessment, to study and understand the neurobiological bases of apathy. We first discuss the paucity of current translational approaches regarding animal equivalents of psychopathological assessment of apathy. We then present the existing evaluation scales for the assessment of apathy in humans and propose five sub-domains of apathy, namely self-care, social interaction, exploration, work/education and recreation. Each of the items in apathy evaluation scales can be assigned to one of these sub-domains. We then show that corresponding, well-validated behavioral readouts exist for rodents and that, indeed, three of the five human apathy sub-domains have a rodent equivalent. In conclusion, the translational ecological study of apathy in humans and mice is possible and will constitute an important approach to increase the understanding of the neurobiological bases of apathy and the development of novel treatments.

1 December 2015 in Schizophrenia Research
Verified
Journal Article
Open access
MHMatthias N. Hartmann-Riemer
Matthias N. Hartmann-Riemer
OHOliver M. Hager
Oliver M. Hager
MKMatthias Kirschner
Matthias Kirschner
MBMartin Bischof
Martin Bischof
AKAgne Kluge
Agne Kluge
SKStefan Kaiser
Stefan Kaiser
Negative symptoms can be grouped into the two dimensions of diminished expression and apathy, which have been shown to be dissociable regarding external validators, such as functional outcome. Here, we investigated whether these two dimensions differentially relate to neurocognitive impairment in schizophrenia. 47 patients with schizophrenia or schizoaffective disorder and 33 healthy control participants were subjected to a neurocognitive test battery assessing multiple cognitive domains (processing speed, working memory, verbal fluency, verbal learning and memory, mental planning), which are integrated into a composite cognition score. Negative symptoms in patients were assessed using the Brief Negative Symptom Scale. We found that diminished expression significantly related to neurocognitive impairment, while severity of apathy symptoms was not directly associated with neurocognition. Other assessed clinical variables include chlorpromazine equivalents, positive symptoms, and depressive symptoms and did not influence the results. Our results are in line with a cognitive resource limitation model of diminished expression in schizophrenia and indicate that cognitive remediation therapy might be helpful to ameliorate expressive deficits.

22 November 2016 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
MBMartin Bischof
Martin Bischof
COCaitriona Obermann
Caitriona Obermann
MHMatthias N. Hartmann
Matthias N. Hartmann
OHOliver M. Hager
Oliver M. Hager
MKMatthias Kirschner
Matthias Kirschner
SKStefan Kaiser
Stefan Kaiser
Negative symptoms are considered core symptoms of schizophrenia. The Brief Negative Symptom Scale (BNSS) was developed to measure this symptomatic dimension according to a current consensus definition. The present study examined the psychometric properties of the German version of the BNSS. To expand former findings on convergent validity, we employed the Temporal Experience Pleasure Scale (TEPS), a hedonic self-report that distinguishes between consummatory and anticipatory pleasure. Additionally, we addressed convergent validity with observer-rated assessment of apathy with the Apathy Evaluation Scale (AES), which was completed by the patient’s primary nurse. Data were collected from 75 in- and outpatients from the Psychiatric Hospital, University Zurich diagnosed with either schizophrenia or schizoaffective disorder. We assessed convergent and discriminant validity, internal consistency and inter-rater reliability. We largely replicated the findings of the original version showing good psychometric properties of the BNSS. In addition, the primary nurses evaluation correlated moderately with interview-based clinician rating. BNSS anhedonia items showed good convergent validity with the TEPS. Overall, the German BNSS shows good psychometric properties comparable to the original English version. Convergent validity extends beyond interview-based assessments of negative symptoms to self-rated anhedonia and observer-rated apathy.

15 June 2016 in Schizophrenia
Verified
Journal Article
Open access
PDF file
MKMatthias Kirschner
Matthias Kirschner
OHOliver M Hager
Oliver M Hager
MBMartin Bischof
Martin Bischof
MHMatthias N Hartmann-Riemer
Matthias N Hartmann-Riemer
AKAgne Kluge
Agne Kluge
SKStefan Kaiser
Stefan Kaiser
Theoretical principles of information processing and empirical findings suggest that to efficiently represent all possible rewards in the natural environment, reward-sensitive neurons have to adapt their coding range dynamically to the current reward context. Adaptation ensures that the reward system is most sensitive for the most likely rewards, enabling the system to efficiently represent a potentially infinite range of reward information. A deficit in neural adaptation would prevent precise representation of rewards and could have detrimental effects for an organism’s ability to optimally engage with its environment. In schizophrenia, reward processing is known to be impaired and has been linked to different symptom dimensions. However, despite the fundamental significance of coding reward adaptively, no study has elucidated whether adaptive reward processing is impaired in schizophrenia. We therefore studied patients with schizophrenia (n=27) and healthy controls (n=25), using functional magnetic resonance imaging in combination with a variant of the monetary incentive delay task. Compared with healthy controls, patients with schizophrenia showed less efficient neural adaptation to the current reward context, which leads to imprecise neural representation of reward. Importantly, the deficit correlated with total symptom severity. Our results suggest that some of the deficits in reward processing in schizophrenia might be due to inefficient neural adaptation to the current reward context. Furthermore, because adaptive coding is a ubiquitous feature of the brain, we believe that our findings provide an avenue in defining a general impairment in neural information processing underlying this debilitating disorder.